Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner

Molecular Biology of the Cell

Volumn 23, Issue 15, 2012, Pages 2943-2954

  Yoo, Jung Yoon ^a   Choi, Hyo Kyoung ^a   Choi, Kyung Chul ^b   Park, Soo Yeon ^a   Ota, Ichiro ^c   Yook, Jong In ^d   Lee, Yoo Hyun ^e   Kim, Kunhong ^a   Yoon, Ho Geun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d Yonsei University College of Dentistry   (South Korea)

^e Suwon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; GAMMA INTERFERON INDUCIBLE PROTEIN 10; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN C JUN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; GENE CONTROL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL;

BINDING SITES; CASEIN KINASE II; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CXCL10; CO-REPRESSOR PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NUCLEAR RECEPTOR CO-REPRESSOR 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEOLYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84864762298     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-11-0947     Document Type: Article

References (40)

1. Aguilera C, Nakagawa K, Sancho R, Chakraborty A, Hendrich B, Behrens A (2011). c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex. Nature 469, 231-235.
2. Babiker AA, Ronquist G, Nilsson B, Ekdahl KN (2006). Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin. Prostate 66, 675-686.
3. Chen YY, Chiang SY, Lin JG, Ma YS, Liao CL, Weng SW, Lai TY, Chung JG (2010). Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncol 36, 1113-1120.
4. Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sorensen ES (2005). Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 390, 285-292.
5. Eferl R, Wagner EF (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3, 859-868.
6. Enderlin M et al. (2009). TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma. Cancer Gene Ther 16, 149-160.
7. Faust RA, Tawfic S, Davis AT, Bubash LA, Ahmed K (2000). Antisense oligonucleotides against protein kinase CK2-α inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck 22, 341-346.
8. Gapany M, Faust RA, Tawfic S, Davis A, Adams GL, Ahmed K (1995). Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Mol Med 1, 659-666.
9. Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, Rosenfeld MG, Glass CK (2009). Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 23, 681-693.
10. Giusiano S et al. (2010). Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays. Eur J Cancer 47, 792-801.
11. Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K (2001). A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem 276, 5992-5999.
12. Hoberg JE, Yeung F, Mayo MW (2004). SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol Cell 16, 245-255.
13. Huang H, Liu Y, Xiang J (2002). Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumors. Cell Immunol 217, 12-22.
14. Jiang Z, Xu Y, Cai S (2010). CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol Biol Rep 37, 3029-3036.
15. Jonas BA, Privalsky ML (2004). SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J Biol Chem 279, 54676-54686.
16. Keyser J, Schultz J, Ladell K, Elzaouk L, Heinzerling L, Pavlovic J, Moelling K (2004). IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency. Exp Dermatol 13, 380-390.
17. Kim HC, et al. (2010). HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell Mol Life Sci 67, 3499-3510.
18. Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC (2001). Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227, 153-165.
19. Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J (2000). Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19, 4342-4350.
20. MacPherson MR, Molina P, Souchelnytskyi S, Wernstedt C, Martin-Perez J, Portillo F, Cano A (2010). Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated kinase protein kinase A. Mol Biol Cell 21, 244-253.
21. Mei K, Wang L, Tian L, Yu J, Zhang Z, Wei Y (2008). Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model. J Exp Clin Cancer Res 27, 63.
22. Peinado H, Ballestar E, Esteller M, Cano A (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 24, 306-319.
23. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG (2004). A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116, 511-526.
24. Perissi V, Jepsen K, Glass CK, Rosenfeld MG (2010). Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet 11, 109-123.
25. Ruzzene M, Pinna LA (2010). Addiction to protein kinase CK2: a common denominator of diverse cancer cells?. Biochim Biophys Acta 1804, 499-504.
26. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B, Behrens A (2009). JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 28, 1843-1854.
27. Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, Jahan I, Tamaya T (2007). Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 96, 1735-1739.
28. Seol W, Mahon MJ, Lee YK, Moore DD (1996). Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol Endocrinol 10, 1646-1655.
29. Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K (2005). Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24, 3532-3542.
30. Soderberg O et al. (2006). Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3, 995-1000.
31. Song DH, Dominguez I, Mizuno J, Kaut M, Mohr SC, Seldin DC (2003). CK2 phosphorylation of the armadillo repeat region of β-catenin potentiates Wnt signaling. J Biol Chem 278, 24018-24025.
32. Tiefenbach J, Novac N, Ducasse M, Eck M, Melchior F, Heinzel T (2006). SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. Mol Biol Cell 17, 1643-1651.
33. Tominaga M, Iwashita Y, Ohta M, Shibata K, Ishio T, Ohmori N, Goto T, Sato S, Kitano S (2007). Antitumor effects of the MIG and IP-10 genes transferred with poly [d,l-2,4-diaminobutyric acid] on murine neuroblastoma. Cancer Gene Ther 14, 696-705.
34. Trembley JH, Wang G, Unger G, Slaton J, Ahmed K (2009). Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci 66, 1858-1867.
35. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J (2003a). Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 22, 1336-1346.
36. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (2003b). N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12, 723-734.
37. Yoon HG, Choi Y, Cole PA, Wong J (2005). Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol Cell Biol 25, 324-335.
38. Zhang J, Kalkum M, Chait BT, Roeder RG (2002). The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9, 611-623.
39. Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH, Wadzinski BE, Seto E (2005). Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev 19, 827-839.
40. Zhou Y, Gross W, Hong SH, Privalsky ML (2001). The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol Cell Biochem 220, 1-13.